Navigation Links
Quantification of the Purinergic Receptor P2X3 using ICAT and ,,, Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer

ortant analytical challenge. As expected, cysteine thiols that occur in highly hydrophobic environments, such as transmembrane protein domains, are less accessible for labeling. In instances like this, the success of the analysis hinges on the ability to efficiently label free thiols (i.e., on cysteines localized in extra-cellular loops), and to resolve and measure the labeled peptides in the midst of a very complex matrix.

We are reporting on the quantification of the membrane receptor P2X3 expressed in HEK cells using ICAT and 2D LC-MS/MS. The P2X family of purino-receptors constitutes a class of ligand-gated ion channels where ATP is the ligand. P2X3 occurs in small diameter sensory neurons and is implicated in the modulation of chronic pain. Goal In this report, we describe the analysis and quantification of the membrane receptor P2X3 using a technique that shows:
  1. The ease-of-use of the ProteomeX Workstation for multi-dimensional separation of complex mixtures.
  2. The ability of TurboSEQUEST software to identify ICAT-labeled proteins.
  3. The power of XPRESS to provide quantitative information for the proteins of interest.
Methods Preparation of Cell Membrane Fractions
Cell membranes used in this experiment were prepared from approximately 110 9 HEK cells, grown to ca. 90% confluency. Cells were harvested in cold PBS, pelleted, re-suspended to 2 mL in PBS and frozen at 80C. The cell suspension was thawed, diluted to 5 mL in cold PBS, and sonicated for 30 seconds followed by ultracentrifugation at 100,000 xg for 1 hou
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Quantification made easy
2. Quantification of siRNA Silencing Efficiency Using the LightCycler System
3. Gene-Expression Analysis of TP, DPD, and TS Using the LightCycler mRNA Quantification KitsPLUS
4. Quantification of Nucleosomes in Serum by the Cell Death Detection ELISAplus
5. Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye
6. DNA Damage and Repair - Quantification of Sub-Cellular Events Using Automated Confocal Imaging
7. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
8. Detecting Gastrin-Releasing Peptide Receptor by in situ PCR on Archived Tissue
9. pFB-ERV: Retroviral Delivery of the Ecdysone Receptor Proteins
10. Gene-Specific Primers for NMDA Receptor Subunits
11. TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins
Post Your Comments:
(Date:3/25/2015)... , March 25, 2015  S&P Capital IQ ... Factual Stock Report coverage on Abattis Bioceuticals Corp ... CSE: ATT): is a specialty biotechnology company with ... licensing and marketing proprietary ingredients, bio-similar compounds, patented ... North America . The company ...
(Date:3/25/2015)... Accelovance, a therapeutically focused contract research organization ... Research Organization" at the upcoming Vaccine Industry Excellence (ViE) ... This is the eighth consecutive year Accelovance has ... for "Best Contract Research Organization" in 2009, 2010, and ... "We,re excited to be a finalist for ...
(Date:3/25/2015)... An increase of awareness related to ... of food nutrients, regulatory changes and concerns related to ... demand for natural astaxanthin over the past few years. ... their capacities to satisfy the rising demand. , ... astaxanthin (used in nutraceuticals, aqua feed, food and beverages ...
(Date:3/25/2015)... 25, 2015 Data from Evidence ... of Action in Neuromuscular Diseases , South ... Incorporated (Nasdaq: CYTK) announced the publication of a ... activator tirasemtiv in the journal Neurotherapeutics. This ... of Effect” or hypothesis-generating clinical trial which evaluated ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards 2Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
... , Gains US Patent Protection for ... (Euronext: AMT), a leader in the field of human ... an exclusive license agreement with the US National Institutes ... 5 (AAV5)-based gene therapy vectors for liver and brain ...
... 2, 2011 This September, during Prostate Cancer Awareness ... cancer screening method that may change the face of ... Cleveland hospitals and one Boston hospital, analyzed by the National ... urine screening. Dr. David Samadi, Vice Chairman, Department of ...
... mysterious inner workings of the malaria parasite has revealed ... thanks in part to a single, crucial chemical that ... the University of California, San Francisco (UCSF) and Stanford ... Biology , this insight immediately provides a powerful new ...
Cached Biology Technology:Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health 2Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health 3More Precise Prostate Cancer Screening on Horizon 2More Precise Prostate Cancer Screening on Horizon 3Malaria discovery gives hope for new drugs and vaccines 2Malaria discovery gives hope for new drugs and vaccines 3Malaria discovery gives hope for new drugs and vaccines 4Malaria discovery gives hope for new drugs and vaccines 5
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... March 10, 2015  Continuing its 167-year history of ... Schlemmer introduces The Eye Scanning Password Authenticator , ... access to secure websites or sensitive data. ... at international borders, the device has a small camera ... of the iris, converting them into an encrypted ID ...
(Date:3/10/2015)... Utah , March 10, 2015   Tute ... interpretation, has been selected by next-generation sequencing company ... of whole exome and targeted gene panel interpretation. ... provider, has adopted the most current technologies to support ... genetic research. The company offers two types of exome ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... Dec. 12, 2011  The Evermedia Group, Inc. (Pinksheets: ... Markets last month, raising the Company,s listing from ... Current Information tier, the highest level of reporting ... Evermedia submitted an Initial Company Information and Disclosure ...
... Cancer Center at University Hospitals (UH) Case Medical Center and ... findings in 25 presentations this weekend at the 53rd Annual ... San Diego Convention Center. "The breadth ... is truly outstanding," says Stan Gerson, MD, Director of the ...
... 15, 2011 The Los Angeles World Airports (LAWA), which ... awarded a contract modification to Unisys (NYSE: UIS ... used to identify the 45,000 airport employees, contractors, police and ... The work is an early step in LAWA,s plan to ...
Cached Biology News:The Evermedia Group, Inc. Advances Corporate Transparency Efforts 2The Evermedia Group, Inc. Advances Corporate Transparency Efforts 3UH Seidman Cancer Center researchers present at American Society of Hematology Annual Meeting 2UH Seidman Cancer Center researchers present at American Society of Hematology Annual Meeting 3Los Angeles World Airports Selects Unisys to Upgrade ID Card Reader System and Network 2Los Angeles World Airports Selects Unisys to Upgrade ID Card Reader System and Network 3
...
Request Info...
... Transformation Kit is designed for rapid ... Advantages over commonly used transformation procedures ... methods include:- Cells can be made competent ... cell preparation and transformation solutions are ...
... Error-free cloning of BAC (100+kb), fosmid (40kb), ... insert stability than any othe BAC vector. ... high yields and easy recombinant DNA purification. ... transcription-free (pSMART VC) vectors for the highest ...
Biology Products: